Enovis Corporation (ENOV) Balance Sheet

The balance sheet has deleveraged in absolute terms, but the reduction in equity is more pronounced, with retained earnings swinging from +$470.5M to -$1.5B over the period. This suggests the company has absorbed significant non-cash charges, likely from the LimaCorporate acquisition and subsequent impairments, which have eroded book value. The stabilization of total assets around $3.8B in recent quarters may indicate the portfolio reshaping is nearing completion, but the equity base remains thin relative to the debt load.

The absolute debt level has been remarkably stable, hovering around $1.4B, but the equity base has contracted by over 50%, causing the D/E ratio to nearly double. This indicates that the company's leverage is not driven by new borrowing but by the erosion of equity from cumulative losses and impairments. The stable debt suggests no urgent refinancing needs, but the rising leverage ratio could constrain financial flexibility if the operating turnaround stalls, especially given the negative net margins.

The dramatic reduction in goodwill—over $1.7B—reflects impairment charges that have cleansed the balance sheet of overvalued acquisition intangibles. Concurrently, the increase in PPE suggests continued investment in manufacturing and instrumentation, which is consistent with a focus on operational assets. This shift from intangible-heavy to tangible-heavy assets may improve the quality of the asset base, but the remaining goodwill of $709.9M still represents a potential impairment risk if the Recon segment underperforms.

The massive swing in retained earnings is driven by cumulative net losses, including a $664.7M impairment in 2024Q4, which has wiped out prior profits. This deficit indicates that the company has not generated sufficient earnings to cover its losses, and the negative equity trend could limit future dividend capacity or share repurchases. However, the recent improvement in operating margins suggests that the bleeding may be slowing, but the retained earnings deficit will take years to repair.

The current ratio remains above 1.5, indicating that current assets cover current liabilities, but the cash position has dwindled to just $12.6M, which is minimal for a company of this size. This suggests that the company is relying on operating cash flow and possibly credit lines to fund working capital needs. The thin cash buffer could be a concern if elective procedure volumes decline or if unexpected expenses arise, but the positive operating cash flow in recent quarters provides some cushion.